“Improving heart failure policy and management in Asia Pacific: Opportunities for impact” is a collaborative work by the APAC CVD Alliance and Deloitte. This White Paper evaluates the current HF policy and management landscape across eight key APAC markets: Australia, China, Hong Kong, Japan, South Korea, Taiwan, Thailand, and Vietnam. It aims to identify critical gaps, uncover areas for intervention, and provide actionable recommendations to drive meaningful improvement in HF policy and care.
Anchored in the APAC CVD Alliance’s broader mandate to drive evidence-based cardiovascular policy reform, the report positions HF as a critical yet under-prioritised component of national health strategies. By mapping the entire continuum of HF care-from prevention and early detection to diagnosis, treatment, and long-term management-the White Paper identifies key policy gaps and system-level inefficiencies, while offering actionable, context-specific recommendations for governments and healthcare stakeholders.
To guide this effort, the Alliance and Deloitte conducted a comprehensive evidence review and convened an advisory panel comprising regional and local experts. Their insights informed a structured benchmarking framework that enabled consistent, comparative evaluation across territories. This scorecard approach highlights both strengths and areas requiring urgent attention and helps prioritise targeted actions for systemic improvement.
We would like to express our sincere thanks to the experts who contributed their time and knowledge to this initiative. Their input has been invaluable in shaping the findings and refining the recommendations.